Taking Charge of Your Hair: The "Big 3 Stack" Explained for 2023 9/13/2023
The "Big 3 Stack" for hair loss treatment, which includes Minoxidil for hair density improvement, Ketoconazole shampoo for enhancing hair volume and thickness, and Finasteride for blocking hair loss causing hormones. Microneedling can boost Minoxidil's effects.
View this post in the Community →
Similar Community Posts Join
6 / 6 resultscommunity 2-Month Progress: 5% Topical Minoxidil + Microneedling (No Finasteride)
The user shared their two-month progress using 5% topical minoxidil and microneedling without finasteride, noting significant hair growth. Other users suggested adding ketoconazole shampoo and discussed microneedling depths, while some expressed skepticism about long-term results without a DHT blocker.
community Before and after? NO Fin/NO Minoxidil. Just DHT Blocking Shampoo&Microneedling
The user experienced hair thinning and used microneedling, DHT blocking shampoo, and Biotin DHT blocking oil to address it, avoiding finasteride and minoxidil unless necessary later. They reported mild improvement but received mixed feedback, with some suggesting other conditions or treatments like ciclopirox shampoo.
community 2 Months Results on 0.25mg Finasteride + Minoxidil + Ketoconazole + Microneedling
The user is seeing early hair growth results from using 0.25mg Finasteride, Minoxidil, Ketoconazole shampoo, and microneedling, with some initial side effects like light aching and decreased libido that are improving. They experienced normal shedding after starting Minoxidil and are considering increasing the Finasteride dose if needed.
community I don’t think my hair loss is caused by DHT – quitting finasteride after 3 months (1 mg). Need opinions
The user plans to stop finasteride after three months, believing hair loss isn't due to DHT, and will continue with oral minoxidil, microneedling, and ketoconazole shampoo. They suspect stress and poor nutrition are the main causes and seek opinions on DHT blockers' effectiveness.
community Will taking DHT blockers at 17 prevent FULL facial bone growth?
A 17-year-old is concerned that taking finasteride might affect facial bone growth and is considering switching to topical finasteride due to its reduced systemic effects. They are also using oral minoxidil and exploring other hair loss treatments like microneedling and ketoconazole shampoo.
community Non fin/min way to ONLY maintain?
The user seeks to maintain hair without using finasteride or minoxidil due to side effects and safety concerns. Suggestions include oral minoxidil, microneedling, ketoconazole shampoo, and a protein-rich diet, but maintaining hair without a DHT blocker is unlikely.
Related Research
6 / 6 resultsresearch Managing patterned hair loss – a hair raising task!
This review summarizes existing knowledge on diffuse and patterned alopecia, emphasizing recent advancements in treatment beyond FDA-approved options, but it reports no new clinical findings.
research Topical solutions for androgenetic alopecia: evaluating efficacy and safety
This review evaluates various topical treatments for androgenetic alopecia but does not provide new clinical findings, emphasizing the need for selecting therapies with limited systemic side effects.
research Molecular Mechanisms and Targeted Therapeutics in Androgenetic Alopecia: From Signaling Pathways to Regenerative Approaches
This review examines androgenetic alopecia, detailing its causes and current treatments, but reports no new clinical results; the authors emphasize understanding its complexity for personalized therapy development.
research Androgenetic alopecia: An update
This study describes androgenetic alopecia as a common non-scarring hair loss condition primarily influenced by genetic factors and androgen sensitivity, notably impacting psychosocial well-being, especially in females and younger males seeking treatment.
research Sulfotransferase SULT1A1 activity in hair follicle, a prognostic marker of response to the minoxidil treatment in patients with androgenetic alopecia: a review
This review discusses the potential of using SULT1A1 expression in the scalp as a biomarker to predict response to minoxidil treatment for androgenetic alopecia, but reports no new clinical results.
research Pathogenic Mechanisms and Mechanism‐Directed Therapies for Androgenetic Alopecia: Current Understanding and Future Directions
In this review, researchers explored key mechanisms underlying androgenetic alopecia, revealing how hormonal, oxidative, inflammatory, and lipid dysregulation suppress hair growth pathways and suggesting new therapeutic targets such as DP2 antagonists and microbiome modulators.